Clinical impact of galectin-3 in newly diagnosed t (15;17)(q22;q21)/PML-RARa acute promyelocytic leukemia treated with all-trans retinoic acid and arsenic trioxide-based regimens
Crossref DOI link: https://doi.org/10.1007/s00277-017-2948-3
Published Online: 2017-02-25
Published Print: 2017-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Gao, Na
Wang, Xue-Xia
Sun, Jian-Rong
Yu, Wen-Zheng
Li, Xi-Zhi
License valid from 2017-02-25